Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Her2-negative Metastatic Breast Cancer × Vinorelbine × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 5 Triple Negative Breast Neoplasms 1 Rhabdomyosarcoma 1 Recurrence 1 Rare Tumour 1 Lung Diseases, Interstitial 1 Hodgkin Disease 1 Her2-negative Metastatic Breast Cancer 1 HER2-positive Advanced Breast Cancer 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

liposomal doxorubicin 1 Vinorelbine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06653972 2024-10-23

EASOVCWDITHABC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting

Her2-negative Metastatic Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡